2014
DOI: 10.1007/s00464-014-4025-5
|View full text |Cite
|
Sign up to set email alerts
|

A pilot study assessing tolerance safety and feasibility of diagnostic transnasal esophagogastroduodenoscopy using an improved larger caliber endoscope and an adapted topical anesthesia

Abstract: Our pilot study demonstrates that TN-EGDS with TNE and NA is safe, well tolerated, and feasible. The best clinical tolerance is reached when TN-EGDS lasts <11 min.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Conversely, VR has shown not only to be effective in pain mitigation in children undergoing circumcisions, active dressing changes in chronic lower limb wounds, gastrointestinal and nasal endoscopies [25][26][27]60], but also to be safe and to increase procedural satisfaction for patients, without disrupting procedural efficiency and workflow [26,27] (Table 2). In particular VR technology may be of aid in nasal gastrointestinal endoscopy, as recently the feasibility and tolerance of this last procedure has been tested even in the absence of deep sedation [61,62].…”
Section: Application Of Vr On Other Proceduresmentioning
confidence: 99%
“…Conversely, VR has shown not only to be effective in pain mitigation in children undergoing circumcisions, active dressing changes in chronic lower limb wounds, gastrointestinal and nasal endoscopies [25][26][27]60], but also to be safe and to increase procedural satisfaction for patients, without disrupting procedural efficiency and workflow [26,27] (Table 2). In particular VR technology may be of aid in nasal gastrointestinal endoscopy, as recently the feasibility and tolerance of this last procedure has been tested even in the absence of deep sedation [61,62].…”
Section: Application Of Vr On Other Proceduresmentioning
confidence: 99%
“…Insertion failure (median 5.8%, range 0–22%), epistaxis (median 2.7%, range 0–33%), and nasal pain (median 35%, range 0–58.3%) associated with UT‐EGD have been reported in the literature, but their ranges are too wide, so is the median visual analogue scale (VAS, 0–5) for nasal pain (1.4 ± 0.4, range 0.8–1.9) . In contrast, the average nasal pain (2.5 ± 0.8, range 1.2–3.7), insertion failure (3.1%, range 0–10.9%), and epistaxis (4.7%, range 0–8.9%) are more convergent and thus reliable to reflect the real‐world data from my study seriers . In brief, the approximately average side effect triad nasal pain (~VAS 2), insertion failure (~3%), and epistaxis (~4%) are tempting for inexperienced endoscopists and patients to accept UT‐EGD.…”
Section: Introductionmentioning
confidence: 99%